Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study.

MLA

Kim, Young-Gun, et al. “Association between Sodium Glucose Co-Transporter 2 Inhibitors and a Reduced Risk of Heart Failure in Patients with Type 2 Diabetes Mellitus: A Real-World Nationwide Population-Based Cohort Study.” Cardiovascular Diabetology, vol. 17, no. 1, June 2018, p. 91. EBSCOhost, https://doi.org/10.1186/s12933-018-0737-5.

APA

Kim, Y.-G., Han, S. J., Kim, D. J., Lee, K.-W., & Kim, H. J. (2018). Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study. Cardiovascular Diabetology, 17(1), 91. https://doi.org/10.1186/s12933-018-0737-5

Chicago

Kim, Young-Gun, Seung Jin Han, Dae Jung Kim, Kwan-Woo Lee, and Hae Jin Kim. 2018. “Association between Sodium Glucose Co-Transporter 2 Inhibitors and a Reduced Risk of Heart Failure in Patients with Type 2 Diabetes Mellitus: A Real-World Nationwide Population-Based Cohort Study.” Cardiovascular Diabetology 17 (1): 91. doi:10.1186/s12933-018-0737-5.